@Hragy @djc795 @DavidLBrownMD @bmsnews Regarding VKA and NOAC: data from health insurance fonds in Europe. Real-world effectiveness and safety of oral anticoagulation strategies | POR @DovePress https://t.co/YNi1BMc3PX
@RayburnTom @RowseMD In Germany mostly Phenprocoumon is Used. Real-world effectiveness and safety of oral anticoagulation strategies | POR @DovePress https://t.co/YNi1BMc3PX
@schneida42 @UK_Muenster Real-world effectiveness and safety of oral anticoagulation strategies | POR @DovePress https://t.co/YNi1BMc3PX
@rafasadaba @kaschenke @fischman_david @mmamas1973 @DocSavageTJU @aayshacader @Pooh_Velagapudi @djc795 @rajivxgulati @chadialraies @DrSheilaSahni @Hragy @NishithChandra @DrMarthaGulati @crfheart Real-world effectiveness and safety of oral anticoagulation s
RT @can_yontar: Real world data...#EPeeps @EPeeps_Bot https://t.co/NEmXp9zjqb
Real world data...#EPeeps @EPeeps_Bot
@DrJasonAndrade @dngibson2 @DoctorPhillEP That's a great one. Re: NOACs I like to quote this "real-world" analysis that finds more strokes, MIs, bleeds and deaths in NOACs versus warfarin. https://t.co/PFuI2r8REr
Étude de cohorte: AOD versus AVK dans la FA : données cliniques de 37 439 patients allemands montrent des risques de saignements majeurs presque deux fois plus élevés avec les AOD @grangeblanche @FZores @T_Nenninger https://t.co/PmJQtyMDpT
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @bogdienache: @djc795 @CMichaelGibson How about when they ask questions where RCTs already exist? https://t.co/VVaMUOm2o6
@djc795 @CMichaelGibson How about when they ask questions where RCTs already exist? https://t.co/VVaMUOm2o6
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
@fluidloading @FZores @pmlallemand Quand les RCT ne marche pas on prend les études « de vraie vie »: https://t.co/Yx3aCntPOl C'est l'inverse pour les AOD: https://t.co/PFuI2r8REr
@ABollmannMD So AF ablation "works" (in the CABANA sense) when non-randomized? Didn't we already know this from the per-protocol analysis? Here's non-randomized study n=180.000 where DOACs have increased mortality, more strokes, more MIs & more bleedi
RT @DebbeMcCall: Avg age 78.2 years. In my 'real world' as a patient, the avg age is 40-50 years. What would this study look like in us?…
RT @edurontoFF: Real-world effectiveness and safety of oral anticoagulation strategies | POR @DovePress https://t.co/O1KThPBibU
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
Interesante 🧐
Real-world effectiveness and safety of oral anticoagulation strategies | POR @DovePress https://t.co/O1KThPBibU
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset. https://t.co/NGN55y4K7b
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
Avg age 78.2 years. In my 'real world' as a patient, the avg age is 40-50 years. What would this study look like in us?
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
RT @AMussigbrodtMD: Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients re…
Should we avoid DOAC in real world patients with atrial fibrillation now? A real world registry with 38.000 patients reported more deaths, more strokes and more bleedings with DOAC than with VKA.https://t.co/aimdOtu0Hn … @ABollmannMD @MDTolgaAksu @EPeeps_